Browse > Article

Mitogenic Estrogen Metabolites Alter the Expression of β-estradiol-regulated Proteins Including Heat Shock Proteins in Human MCF-7 Breast Cancer Cells  

Kim, Seong Hwan (Laboratory of Chemical Genomics, Bio-Organic Science Division, Korea Research Institute of Chemical Technology)
Lee, Su-Ui (Laboratory of Chemical Genomics, Bio-Organic Science Division, Korea Research Institute of Chemical Technology)
Kim, Myung Hee (Laboratory of Chemical Genomics, Bio-Organic Science Division, Korea Research Institute of Chemical Technology)
Kim, Bum Tae (Laboratory of Chemical Genomics, Bio-Organic Science Division, Korea Research Institute of Chemical Technology)
Min, Yong Ki (Laboratory of Chemical Genomics, Bio-Organic Science Division, Korea Research Institute of Chemical Technology)
Abstract
Estrogen metabolites are carcinogenic. The comparative mitogenic activities of $17{\beta}$-estradiol (E2) and four metabolites, 2-hydroxyestradiol (2-OHE2), 4-hydroxyestradiol (4-OHE2), $16{\alpha}$-hydroxyestrone ($16{\alpha}$-OHE1) and 2-methoxyestradiol (2-ME), were determined in estrogen receptor(ER)-positive MCF-7 human breast cancer cells. Each of the E2 metabolites caused proliferation of the MCF-7 cells, but only E2 and $16{\alpha}$-OHE1 induced a greater than 20-fold increases in transcripts of the progesterone receptor (PR) gene, a classical ER-mediated gene. This suggests that the mitogenic action of E2 and $16{\alpha}$-OHE1 could result from their effects on gene expression via the ER. E2 metabolites altered the expression of E2-regulated proteins including heat shock proteins (Hsps). $16{\alpha}$-OHE1 and 2-ME as well as E2 increased levels of Hsp56, Hsp60, $Hsp90{\alpha}$ and Hsp110 transcripts, and the patterns of these inductions resembled that of PR. Hsp56 and Hsp60 protein levels were increased by all the E2 metabolites. Levels of the transcripts of 3 E2-upregulated proteins (XTP3-transactivated protein A, protein disulfide isomerase-associated 4 protein and stathmin 1) and an E2-downregulated protein (aminoacylase 1) were also affected by the E2 metabolites. These results suggest that the altered expression of Hsps (especially Hsp56 and Hsp60) by E2 metabolites such as E2, $16{\alpha}$-OHE1 and 2-ME could be closely linked to their mitogenic action.
Keywords
2-Hydroxyestradiol; 2-Methoxyestradiol; 4-Hydroxyestradiol; $16{\alpha}$-Hydroxyestrone; $17{\beta}$-Estradiol; Breast Cancer; Heat Shock Proteins;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By Web Of Science : 10  (Related Records In Web of Science)
연도 인용수 순위
1 Beliakoff, J. and Whitesell, L. (2004) Hsp90: an emerging target for breast cancer therapy. Anticancer Drugs 15, 651-662   DOI   ScienceOn
2 Cook, R. M., Franklin, W. A., Moore, M. D., Johnson, B. E., and Miller, Y. E. (1998) Mutational inactivation of aminoacylase- I in a small cell lung cancer cell line. Genes Chromosomes Cancer 21, 320-325   DOI   ScienceOn
3 Fishman, J. and Martucci, C. (1980) Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology. Clin. Endocrinol Metab. 51, 611-615   DOI
4 Nardulli, A. M., Greene, G. L., O'Malley, B. W., and Katzenellenbogen, B. S. (1988) Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 122, 935-944   DOI   ScienceOn
5 Schumacher, G. and Neuhaus, P. (2001) The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors. J. Cancer Res. Clin. Oncol. 127, 405-410   DOI
6 Soufla, G., Porichis, F., Sourvinos, G., Vassilaros, S., and Spandidos, D. A. (2005) Transcription deregulation of VEGF, FGF2, TGF-${\betha}$ 1, 2, 3 and cognate receptors in breast tumorigenesis. Cancer Lett. [Epud ahead of print]
7 Ward, B. K., Mark, P. J., Ingram, D. M., Minchin, R. F., and Ratajczak, T. (1999) Expression of the estrogen receptorassociated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res. Treat. 58, 267-280
8 Cappello, F., Bellafiore, M., Palma, A., David, S., Marciano, V., et al. (2003) 60 Kda chaperonin (HSP60) is over-expressed during colorectal carcinogenesis. Eur. J. Histochem. 47, 105-110
9 Liehr, J. G. and Ricci, M. J. (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA 93, 3294-3296
10 Liehr, J. G., Fang, W. F., Sirbasku, D. A., and Ari-Ulubelen, A. (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24, 353-356   DOI   ScienceOn
11 Cappello, F., Bellafiore, M., Palma, M. A., Marciano, V., Martorana, G., et al. (2002-2003) Expression of 60-kDa heat shock protein increases during carcinogenesis in the uterine exocervix. Pathobiology 70, 83-88   DOI   ScienceOn
12 Clemons, M. and Goss, P. (2001) Estrogen and the risk of breast cancer. N. Engl. J. Med. 344, 276-285   DOI   ScienceOn
13 Liu, Z. J. and Zhu, B. T. (2004) Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J. Steroid Biochem. Mol. Biol. 88, 265-275   DOI   ScienceOn
14 Oh, W. K. and Song, J. (2003) Cooperative interaction of Hsp40 and TPR1 with Hsp70 reverses Hsp70-HspBp1 complex formation. Mol. Cells 16, 84-91
15 Gupta, M., McDougal, A., and Safe, S. (1998) Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. J. Steroid Biochem. Mol. Biol. 67, 413-419   DOI   ScienceOn
16 Isaacs, J. S., Xu, W., and Neckers, L. (2003) Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3, 213-217   DOI   ScienceOn
17 Flouriot, G., Brand, H., Denger, S., Metivier, R., Kos, M., et al. (2000) Identification of a new isoform of the human estrogen receptor-${\alpha}$ (hER-${\alpha}$) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J. 19, 4688-4700   DOI   ScienceOn
18 Rogan, E. G., Badawi, A. F., Devanesan, P. D., Meza, J. L., Edney, J. A., et al. (2003) Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24, 697-702   DOI   ScienceOn
19 Rozen, S. and Skaletsky, H. J. (2000) Primer3 on the WWW for general users and for biologist programmers; in Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz, S. and Misener, S. (eds.), pp. 365-386, Humana Press, Totowa
20 Kumar, P., Mark, P. J., Ward, B. K., Minchin, R. F., and Ratajczak, T. (2001) Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 284, 219-225   DOI   ScienceOn
21 Darbre, P., Yates, J., Curtis, S., and King, R. J. (1983) Effect of estradiol on human breast cancer cells in culture. Cancer Res. 43, 349-354
22 Fishman, J., Schneider, J., Hershcope, R. J., and Bradlow, H. L. (1984) Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. Steroid Biochem. 20, 1077-1081   DOI   ScienceOn
23 Lewis, J. S., Thomas, T. J., Klinge, C. M., Gallo, M. A., and Thomas, T. (2001) Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in MCF-7 breast cancer cells. J. Mol. Endocrinol. 27, 293-307   DOI   ScienceOn
24 Lippert, C., Seeger, H., and Mueck, A. O. (2003) The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci. 72, 877-883   DOI   ScienceOn
25 Lorenzo, J. (2003) A new hypothesis for how sex steroid hormones regulate bone mass. J. Clin. Invest. 111, 1641-1643   DOI   ScienceOn
26 Horwitz, K. B. and McGuire, W. L. (1978) Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. Biol. Chem. 253, 2223-2228
27 Newbold, R. R. and Liehr, J. G. (2000) Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res. 60, 235-237
28 Swaneck, G. E. and Fishman, J. (1988) Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl. Acad. Sci. USA 85, 7831-7835
29 Curmi, P. A., Nogues, C., Lachkar, S., Carelle, N., Gonthier, M. P., et al. (2000) Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br. J. Cancer 82, 142-150   DOI   ScienceOn
30 Balabanov, S., Zimmermann, U., Protzel, C., Scharf, C., Klebingat, K. J., et al. (2001) Tumor-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. Eur. J. Biochem. 268, 5977-5980   DOI   ScienceOn
31 McGuire, W. L., Horwitz, K. B., Chamness, G. C., and Zava, D. T. (1976) A physiological role for estrogen and progesterone in breast cancer. J. Steroid Biochem. 7, 875-882   DOI   ScienceOn
32 Schneider, J., Kinne, D., Fracchia, A., Pierce, V., Anderson, K. E., et al. (1982) Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl. Acad. Sci. USA 79, 3047-3051
33 Schutze, N., Vollmer, G., Tiemann, I., Geiger, M., and Knuppen, R. (1993) Catecholestrogens are MCF-7 cell estrogen receptor agonists. J. Steroid Biochem. Mol. Biol. 46, 781-789   DOI   ScienceOn
34 Kim, S. H., Lee, S., Kim, M. H., Kim, B. T., and Min, Y. K. (2005) Protein profiling and transcript expression levels of heat shock proteins in 17${\beta}$ -estradiol-treated human MCF-7 breast cancer cells. (submitted)
35 Wang, X. Y., Chen, X., Manjili, M. H., Repasky, E., Henderson, R., et al. (2003) Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma- associated antigen gp100. Cancer Res. 63, 2553-2560
36 Lippert, T. H., Seeger, H., and Mueck, A. O. (2000) The impact of endogenous estradiol metabolites on carcinogenesis. Steroids 65, 357-369   DOI   ScienceOn
37 Seegers, J. C., Aveling, M. L., Van Aswegen, C. H., Cross, M., Koch, F., et al. (1989) The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J. Steroid Biochem. 32, 797-809   DOI   ScienceOn
38 Hwang, T. S., Han, H. S., Choi, H. K., Lee, Y. J., Kim, Y. J., et al. (2003) Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J. Gastroenterol. Hepatol. 18, 690-700   DOI   ScienceOn
39 Li, J. J. and Li, S. A. (1987) Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc. 46, 1858-1863
40 Ernst, M., Schmid, C., and Froesch, E. R. (1989) Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo. Steroid Biochem. 33, 907-914   DOI   ScienceOn
41 Csermely, P., Schnaider, T., Soti, C., Prohaszka, Z., and Nardai, G. (1998) The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol. Ther. 79, 129-168   DOI   ScienceOn
42 Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the $2^{-{\Delta}{\Delta}{\Delta}C}T$ method. Methods 25, 402-408   DOI   ScienceOn
43 Peattie, D. A., Harding, M. W., Fleming, M. A., DeCenzo, M. T., Lippke, J. A., et al. (1992) Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc. Natl. Acad. Sci. USA 89, 10974-10978
44 Frydman, J. and Hart, F. U. (1996) Principles of chaperoneassisted protein folding: differences between in vitro and in vivo mechanisms. Science 272, 1497-1502   DOI   ScienceOn